Glimepiride, a novel soluble epoxide hydrolase inhibitor, protects against heart failure via increasing epoxyeicosatrienoic acids - Journal of Molecular and Cellular Cardiology

May 15,2024

Glimepiride, a novel soluble epoxide hydrolase inhibitor, protects

BRG1 and BRM function antagonistically with c-MYC in adult

Mechanisms of Cardiovascular Benefits of Sodium Glucose Co

Innate Immune Nod1/RIP2 Signaling Is Essential for Cardiac

PDF) Epoxide hydrolase 1 (EPHX1) hydrolyzes epoxyeicosanoids and

Soluble epoxide hydrolase inhibition and gene deletion are

Therapeutic and Prognostic Significance of Arachidonic Acid in

Soluble epoxide hydrolase inhibition and gene deletion are

Discovery of Novel Soluble Epoxide Hydrolase Inhibitors as Potent

Glimepiride, a novel soluble epoxide hydrolase inhibitor, protects

Selective inhibition of class I but not class IIb histone

Optimization of Amide-Based Inhibitors of Soluble Epoxide

Soluble epoxide hydrolase inhibition and gene deletion are

Optimized Inhibitors of Soluble Epoxide Hydrolase Improve in Vitro

TGF-β1 induces cardiac hypertrophic responses via PKC-dependent